186 related articles for article (PubMed ID: 33834526)
1. Fontan-associated liver disease and total cavopulmonary anatomical flow effectors.
Evans WN; Acherman RJ; Galindo A; Rothman A; Ciccolo ML; Lehoux J; Winn BJ; Yumiaco NS; Restrepo H
J Card Surg; 2021 Jul; 36(7):2329-2335. PubMed ID: 33834526
[TBL] [Abstract][Full Text] [Related]
2. The Rate of Hepatic Fibrosis Progression in Patients Post-Fontan.
Evans WN; Acherman RJ; Mayman GA; Galindo A; Rothman A; Winn BJ; Yumiaco NS; Restrepo H
Pediatr Cardiol; 2020 Jun; 41(5):905-909. PubMed ID: 32125444
[TBL] [Abstract][Full Text] [Related]
3. A composite noninvasive index correlates with liver fibrosis scores in post-Fontan patients: Preliminary findings.
Evans WN; Acherman RJ; Ciccolo ML; Carrillo SA; Galindo A; Rothman A; Mayman GA; Adams EA; Reardon LC; Winn BJ; Yumiaco NS; Shimuizu L; Inanaga Y; Deleon RJ; Restrepo H
Congenit Heart Dis; 2018 Jan; 13(1):38-45. PubMed ID: 29194972
[TBL] [Abstract][Full Text] [Related]
4. Fontan-Associated Anatomical Variants and Hepatic Fibrosis.
Evans WN; Acherman RJ; Mayman GA; Galindo A; Rothman A; Ciccolo ML; Lehoux J; Winn BJ; Yumiaco NS; Restrepo H
World J Pediatr Congenit Heart Surg; 2021 Mar; 12(2):168-172. PubMed ID: 33684008
[TBL] [Abstract][Full Text] [Related]
5. Hepatic fibrosis gender differences in extracardiac Fontan patients.
Evans WN; Acherman RJ; Restrepo H
J Card Surg; 2022 Nov; 37(11):3520-3524. PubMed ID: 36057990
[TBL] [Abstract][Full Text] [Related]
6. Fontan venovenous collaterals and hepatic fibrosis.
Evans WN; Acherman RJ; Mayman GA; Galindo A; Rothman A; Ciccolo ML; Lehoux J; Winn BJ; Yumiaco NS; Restrepo H
J Card Surg; 2020 Nov; 35(11):2974-2978. PubMed ID: 32789925
[TBL] [Abstract][Full Text] [Related]
7. Impact of hemodynamics and fluid energetics on liver fibrosis after Fontan operation.
Trusty PM; Wei Z; Rychik J; Russo PA; Surrey LF; Goldberg DJ; Fogel MA; Yoganathan AP
J Thorac Cardiovasc Surg; 2018 Jul; 156(1):267-275. PubMed ID: 29609888
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Fibrosis Risk Factors in Extracardiac-Fontan Patients: Observations From a Single Center.
Evans WN; Acherman RJ; Galindo A; Rothman A; Ciccolo ML; Lehoux J; Restrepo H
World J Pediatr Congenit Heart Surg; 2023 May; 14(3):345-349. PubMed ID: 36883214
[No Abstract] [Full Text] [Related]
9. Transvenous hepatic biopsy in stable Fontan patients undergoing cardiac catheterization.
Evans WN; Winn BJ; Yumiaco NS; Galindo A; Rothman A; Acherman RJ; Restrepo H
Pediatr Cardiol; 2014 Oct; 35(7):1273-8. PubMed ID: 24817681
[TBL] [Abstract][Full Text] [Related]
10. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis.
Wu FM; Opotowsky AR; Raza R; Harney S; Ukomadu C; Landzberg MJ; Valente AM; Breitbart RE; Singh MN; Gauvreau K; Jonas MM
Congenit Heart Dis; 2014; 9(5):438-47. PubMed ID: 24418160
[TBL] [Abstract][Full Text] [Related]
11. Pretransplantation and Post-Transplantation Liver Disease Assessment in Adolescents Undergoing Isolated Heart Transplantation for Fontan Failure.
Rodriguez DS; Mao C; Mahle WT; Kanter KR; Alazraki A; Braithwaite K; Rytting H; Caltharp S; Magliocca JF; Romero R
J Pediatr; 2021 Feb; 229():78-85.e2. PubMed ID: 32976893
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients.
Wu FM; Earing MG; Aboulhosn JA; Johncilla ME; Singh MN; Odze RD; Ukomadu C; Gauvreau K; Landzberg MJ; Valente AM;
J Heart Lung Transplant; 2017 Feb; 36(2):211-219. PubMed ID: 27592026
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Fontan liver disease: Correlation of transjugular liver biopsy with magnetic resonance and hemodynamics.
Silva-Sepulveda JA; Fonseca Y; Vodkin I; Vaughn G; Newbury R; Vavinskaya V; Dwek J; Perry JC; Reshamwala P; Baehling C; Lyon J; Davis C; Lee JW; El-Sabrout H; Shahbah D; Alshawabkeh L; Moore JW; El-Said H
Congenit Heart Dis; 2019 Jul; 14(4):600-608. PubMed ID: 31038848
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Fibrosis Is Universal Following Fontan Operation, and Severity is Associated With Time From Surgery: A Liver Biopsy and Hemodynamic Study.
Goldberg DJ; Surrey LF; Glatz AC; Dodds K; O'Byrne ML; Lin HC; Fogel M; Rome JJ; Rand EB; Russo P; Rychik J
J Am Heart Assoc; 2017 Apr; 6(5):. PubMed ID: 28446492
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Magnetic Resonance-Derived Metrics Are Predictive of Liver Fibrosis in Fontan Patients.
Trusty PM; Wei ZA; Rychik J; Graham A; Russo PA; Surrey LF; Goldberg DJ; Yoganathan AP; Fogel MA
Ann Thorac Surg; 2020 Jun; 109(6):1904-1911. PubMed ID: 31734244
[TBL] [Abstract][Full Text] [Related]
16. Severity of Fontan-Associated Liver Disease Correlates with Fontan Hemodynamics.
Schleiger A; Salzmann M; Kramer P; Danne F; Schubert S; Bassir C; Müller T; Müller HP; Berger F; Ovroutski S
Pediatr Cardiol; 2020 Apr; 41(4):736-746. PubMed ID: 32006084
[TBL] [Abstract][Full Text] [Related]
17. Haemodynamic and prognostic associations of liver fibrosis scores in Fontan-associated liver disease.
Martin de Miguel I; Kamath PS; Egbe AC; Jain CC; Cetta F; Connolly HM; Miranda WR
Heart; 2023 Mar; 109(8):619-625. PubMed ID: 36581444
[TBL] [Abstract][Full Text] [Related]
18. Does liver biopsy accurately measure fibrosis in Fontan-associated liver disease? A comparison of liver biopsy pre-combined heart and liver transplant and liver explant post-transplant.
Vaikunth SS; Higgins JP; Concepcion W; Haeffele C; Wright GE; Chen S; Lui GK; Daugherty T
Clin Transplant; 2020 Dec; 34(12):e14120. PubMed ID: 33053213
[TBL] [Abstract][Full Text] [Related]
19. Liver health in adults with Fontan circulation: A multicenter cross-sectional study.
Wu FM; Kogon B; Earing MG; Aboulhosn JA; Broberg CS; John AS; Harmon A; Sainani NI; Hill AJ; Odze RD; Johncilla ME; Ukomadu C; Gauvreau K; Valente AM; Landzberg MJ;
J Thorac Cardiovasc Surg; 2017 Mar; 153(3):656-664. PubMed ID: 27955914
[TBL] [Abstract][Full Text] [Related]
20. Transjugular liver biopsy for Fontan associated liver disease surveillance: Technique, outcomes and hemodynamic correlation.
Borquez AA; Silva-Sepulveda J; Lee JW; Vavinskaya V; Vodkin I; El-Sabrout H; Towbin R; Perry JC; Moore JW; El-Said HG
Int J Cardiol; 2021 Apr; 328():83-88. PubMed ID: 33278420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
